News 2016-08-25
Porton Hosts An Investor Reception, August 25, 2016.
Changshou [Chongqing Metropolitan Region], China, August 25, 2016: Porton proudly hosted a delegation of >50 investment analysts and corporate finance media professionals from the Shenzhen Stock Exchange at its USFDA-inspected production facility in Changshou, The guests were hosted by Porton Vice-Presidents Mr. Richard Tao, Dr. Tim Yu and Mr. Victor Cao and toured the site, which produces and supplies custom drug intermediates and APIs for many of the world’s most well-known and respected pharmaceutical and biotechnology companies.
Others
More
News 2024-10-31
Milestone | Comprehensive Enhancement of GMP Manufacturing Capacity and New Modality Service Capabilities at Porton Fengxian, Shanghai
Recently, Porton Pharma has achieved a significant capacity breakthrough at its GMP manufacturing facility in Fengxian, Shanghai, China, further enhancing its production capabilities and technological strength in new modality areas such as peptide and oligonucleotide drugs. This upgrade represents an important step in Porton's commitment to becoming a leading global CDMO company.
News 2024-10-24
Porton Pharma Solutions Signed Strategic Partnership with Shanghai InnoStar
On October 24, 2024, Porton Pharma SolutionsLtd. ("Porton") announced a strategic partnership with Shanghai InnoStar Bio-tech Co., Ltd. ("InnoStar") in Shanghai. The distinguished signing ceremony was attended by Mr. Ju Nianfeng, Chairman and CEO of Porton; Dr. Chang Yan, President of InnoStar; Ms. Pi Wei, Deputy General Manager of Porton; Ms. Fan Meng, Deputy General Manager of the Sales & Marketing Center, Dr. Fang Xin, Senior Director of Non-clinicalPharmacology BU at InnoStar, and Ms. Zhao Jie, Marketing Associate Director at InnoStar.
